A California ride-share driver advocacy group, Rideshare Drivers United (RDU), has filed a lawsuit against Uber, alleging the company violated Proposition 22. The complaint claims Uber terminates drivers improperly, lacks a fair appeals process, restricts drivers from declining rides, and withholds earnings information. RDU seeks a court declaration that Uber is disqualified from classifying its drivers as independent contractors due to these alleged breaches.

Textron Inc. (US8832031027) is presented as a diversified industrial company with strong positions in aviation, defense, and manufacturing. Its business model, spread across segments like Textron Aviation, Bell Helicopters, and Textron Systems, aims to provide stability and growth potential for investors. The article highlights Textron's competitive advantages, strategic initiatives, and relevance for investors in the United States and English-speaking markets, while also addressing inherent risks and current analyst views.

Revvity Inc. (US76155R1086) provides tools for drug discovery and diagnostics, positioning it in the life sciences sector with robust demand. The company's core business model focuses on precision tools for research and diagnostics, emphasizing recurring revenue from consumables and services. Revvity aims for long-term growth through strategic investments in high-growth areas like cell and gene therapy, digital integration, and global expansion, while facing risks from biopharma budget cuts and competitive pressure.

Google's 2026 Discover Core Update is revolutionizing how retail investors access information on Prudential Financial stock (US7443201022). This update prioritizes personalized, mobile-first financial content, delivering insights on insurance trends, retirement planning, and annuity growth directly to users' Google app feeds. The change aims to provide faster, more tailored decision-making tools for investors by leveraging past Web and App activity to surface relevant E-E-A-T content.

Merck & Co., Inc. announced that the European Commission has approved ENFLONSIA (clesrovimab) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. This preventive, long-acting monoclonal antibody provides up to five months of protection and is now approved for marketing across all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. ENFLONSIA has also been approved in the U.S., Canada, Switzerland, and other markets, with Merck continuing to seek approvals globally.

News Corp (Class B) leverages a diversified business model encompassing news media, book publishing, and digital real estate to achieve resilience against market volatility. Its strategy focuses on premium content, digital transformation, and expanding real estate platforms, aiming for consistent cash flows and high-margin opportunities. Analysts generally view the stock favorably due to its diversified revenue streams and undervaluation, despite some caution regarding media ad cyclicality and competition from big tech.

Westlake Chemical Partners LP announced that Jonathan H. Baksht will join as Senior Vice President and Chief Financial Officer effective June 15, 2026, succeeding M. Steven Bender. Baksht brings extensive experience from various CFO roles in the oil and gas, packaging, and building products industries. This leadership change comes as parent company Westlake Chemical Corporation shows strong market performance, with shares up 53% year-to-date and positive analyst outlooks.

The Rosen Law Firm is investigating potential securities claims against Zillow Group, Inc. (NASDAQ: Z, ZG) following allegations of materially misleading business information. This investigation stems from an FTC lawsuit filed on September 30, 2025, concerning an illegal agreement between Zillow and Redfin to suppress rental advertising competition, which led to a 4.6% drop in Zillow's Class C stock. Investors who suffered losses after purchasing Zillow securities are encouraged to contact the law firm to explore their rights and potentially join a class action lawsuit for compensation.

Bank of America and Mizuho Financial Group have each lowered their price targets for American International Group, Inc. (AIG), while maintaining a Neutral rating on the stock. These adjustments were made to reflect Q4 developments, updated peer multiples, and revised estimates across US and North America insurance coverage. Despite the reduced price targets, AIG's management reaffirmed its focus on growth in its General Insurance segment and cost discipline, aiming to bring its expense ratio below 30% by 2027.

MSCI Inc. has extended its review period for Indonesia's stock market status until June to assess regulatory reforms, delaying passive inflows but providing more time for policymakers. This follows months of investor concern over a potential downgrade to frontier status due to investibility and free-float issues, which had led to market turmoil and reforms like increased minimum float levels. The extension is seen as a neutral-to-slightly negative development in the short term but offers a "path to redemption" in the long run.